Geirmund Myklebust

1.3k total citations
28 papers, 870 citations indexed

About

Geirmund Myklebust is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Nephrology. According to data from OpenAlex, Geirmund Myklebust has authored 28 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 22 papers in Rheumatology and 6 papers in Nephrology. Recurrent topics in Geirmund Myklebust's work include Vasculitis and related conditions (22 papers), Otitis Media and Relapsing Polychondritis (14 papers) and Systemic Lupus Erythematosus Research (6 papers). Geirmund Myklebust is often cited by papers focused on Vasculitis and related conditions (22 papers), Otitis Media and Relapsing Polychondritis (14 papers) and Systemic Lupus Erythematosus Research (6 papers). Geirmund Myklebust collaborates with scholars based in Norway, United States and Switzerland. Geirmund Myklebust's co-authors include Jan Tore Gran, Andreas P. Diamantopoulos, Glenn Haugeberg, Bjarne K. Jacobsen, Tom Wilsgaard, D.M. Soldal, Rolf Bruun Bie, Johan G. Brun, Are Hugo Pripp and J. B. Andersen and has published in prestigious journals such as Annals of the Rheumatic Diseases, BioMed Research International and Lara D. Veeken.

In The Last Decade

Geirmund Myklebust

26 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geirmund Myklebust Norway 12 772 605 288 110 106 28 870
Frances Borg United Kingdom 12 814 1.1× 678 1.1× 318 1.1× 101 0.9× 84 0.8× 17 988
Montserrat Butjosa Spain 10 693 0.9× 504 0.8× 200 0.7× 100 0.9× 97 0.9× 12 774
G. Restuccia Italy 15 681 0.9× 487 0.8× 208 0.7× 121 1.1× 55 0.5× 20 748
Itziar Tavera-Bahillo Spain 11 852 1.1× 603 1.0× 209 0.7× 120 1.1× 169 1.6× 13 900
Pilar Rodríguez‐Ledo Spain 4 726 0.9× 440 0.7× 138 0.5× 204 1.9× 102 1.0× 6 788
Jean‐François Cordier France 6 877 1.1× 471 0.8× 166 0.6× 107 1.0× 333 3.1× 6 1000
D. Prieto-Peña Spain 14 408 0.5× 347 0.6× 130 0.5× 48 0.4× 73 0.7× 61 576
Claudia Metzler Germany 10 723 0.9× 581 1.0× 148 0.5× 48 0.4× 269 2.5× 16 878
Madeline Whitlock United Kingdom 3 566 0.7× 411 0.7× 116 0.4× 89 0.8× 146 1.4× 3 613
P. Letellier France 9 563 0.7× 453 0.7× 129 0.4× 54 0.5× 120 1.1× 29 674

Countries citing papers authored by Geirmund Myklebust

Since Specialization
Citations

This map shows the geographic impact of Geirmund Myklebust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geirmund Myklebust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geirmund Myklebust more than expected).

Fields of papers citing papers by Geirmund Myklebust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geirmund Myklebust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geirmund Myklebust. The network helps show where Geirmund Myklebust may publish in the future.

Co-authorship network of co-authors of Geirmund Myklebust

This figure shows the co-authorship network connecting the top 25 collaborators of Geirmund Myklebust. A scholar is included among the top collaborators of Geirmund Myklebust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geirmund Myklebust. Geirmund Myklebust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molberg, Øyvind, et al.. (2025). Mortality in polymyalgia rheumatica: a 38-year prospective population-based cohort study from Southern Norway. Arthritis Research & Therapy. 27(1). 154–154.
2.
Diamantopoulos, Andreas P., et al.. (2024). Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with Polymyalgia Rheumatica: a narrative review. BMC Rheumatology. 8(1). 58–58. 1 indexed citations
3.
Andel, Peter M, Andreas P. Diamantopoulos, Geirmund Myklebust, & Glenn Haugeberg. (2023). Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR/EULAR classification criteria. Frontiers in Medicine. 10. 1286601–1286601. 5 indexed citations
4.
Bakland, Gunnstein, et al.. (2023). Norwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis. Frontiers in Medicine. 9. 1082604–1082604. 11 indexed citations
5.
Fevang, Bjørg‐Tilde Svanes, et al.. (2023). Giant cell arteritis: incidence and phenotypic distribution in Western Norway 2013–2020. Frontiers in Medicine. 10. 1296393–1296393. 6 indexed citations
6.
Geiger, Julia, et al.. (2020). Magnetic resonance imaging compared to ultrasonography in giant cell arteritis: a cross-sectional study. Arthritis Research & Therapy. 22(1). 247–247. 16 indexed citations
7.
Andersen, J. B., Geirmund Myklebust, Glenn Haugeberg, Are Hugo Pripp, & Andreas P. Diamantopoulos. (2020). Incidence Trends and Mortality of Giant Cell Arteritis in Southern Norway. Arthritis Care & Research. 73(3). 409–414. 18 indexed citations
8.
9.
Diamantopoulos, Andreas P. & Geirmund Myklebust. (2014). Long-term inflammation in the temporal artery of a giant cell arteritis patient as detected by ultrasound. Therapeutic Advances in Musculoskeletal Disease. 6(3). 102–103. 9 indexed citations
10.
11.
Myklebust, Geirmund, et al.. (2013). Leflunomide as a corticosteroid-sparing agent in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR): A consecutive case series. La Presse Médicale. 42(4). 726–727. 3 indexed citations
12.
Diamantopoulos, Andreas P., et al.. (2011). Severe deterioration of newly diagnosed Takayasu arteritis in a patient re-treated with interferon beta-1α for concomitant longstanding multiple sclerosis. Modern Rheumatology. 22(3). 474–478. 2 indexed citations
13.
Brun, Johan G., et al.. (2005). A longitudinal study of calprotectin in patients with polymyalgia rheumatica or temporal arteritis: relation to disease activity. Scandinavian Journal of Rheumatology. 34(2). 125–128. 23 indexed citations
14.
Myklebust, Geirmund, Tom Wilsgaard, Bjarne K. Jacobsen, & Jan Tore Gran. (2003). Causes of death in polymyalgia rheumaticaA prospective longitudinal study of 315 cases and matched population controls. Scandinavian Journal of Rheumatology. 32(1). 38–41. 20 indexed citations
15.
Gran, Jan Tore & Geirmund Myklebust. (2001). Diagnostikk av primært Sjögrens syndrom. Tidsskrift for Den Norske Laegeforening.
16.
Gran, Jan Tore, Geirmund Myklebust, Tom Wilsgaard, & Bjarne K. Jacobsen. (2001). Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Lara D. Veeken. 40(11). 1238–1242. 82 indexed citations
17.
Gran, Jan Tore & Geirmund Myklebust. (1997). The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94.. PubMed. 24(9). 1739–43. 97 indexed citations
18.
19.
Gran, Jan Tore, et al.. (1993). Adutt Idiopathic Polymyositis without Elevation of Creatine KinaseCase report and review of the literature. Scandinavian Journal of Rheumatology. 22(2). 94–96. 10 indexed citations
20.
Gran, Jan Tore & Geirmund Myklebust. (1992). The Concomitant Occurrence of Sjögren's Syndrome and Polymyositis. Scandinavian Journal of Rheumatology. 21(3). 150–154. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frances Borg Breakdown of academic impact, for papers by Montserrat Butjosa Breakdown of academic impact, for papers by G. Restuccia Breakdown of academic impact, for papers by Itziar Tavera-Bahillo Breakdown of academic impact, for papers by Pilar Rodríguez‐Ledo Breakdown of academic impact, for papers by Jean‐François Cordier Breakdown of academic impact, for papers by D. Prieto-Peña Breakdown of academic impact, for papers by Claudia Metzler Breakdown of academic impact, for papers by Madeline Whitlock Breakdown of academic impact, for papers by P. Letellier
Rankless by CCL
2026